Topical effects of cidofovir on cutaneous rabbit warts: Treatment regimen and inoculum dependence

Antiviral Research

Volumn 46, Issue 2, 2000, Pages 135-144

  Duan, Jianmin ^a   Paris, William ^a   De Marte, Josie ^a   Roopchand, Diana ^a   Fleet, Tamara Louise ^a   Cordingley, Michael G ^a  

^a BOEHRINGER INGELHEIM CANADA LTD   (Canada)

Author keywords

Cidofovir; Cottontail rabbit papillomavirus (CRPV); Papilloma; Rabbits; Warts

Indexed keywords

CIDOFOVIR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTIVIRAL ACTIVITY; ARTICLE; DRUG EXPOSURE; ERYTHEMA; INOCULATION; NECROSIS; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; RABBIT; VERRUCA VULGARIS;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIVIRAL AGENTS; COTTONTAIL RABBIT PAPILLOMAVIRUS; CYTOSINE; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; FEMALE; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; RABBITS; TIME FACTORS; WARTS;

ANIMALIA; COTTONTAIL RABBIT PAPILLOMAVIRUS; DNA VIRUSES; ORYCTOLAGUS CUNICULUS; PAPILLOMAVIRUS; VERRUCA;

EID: 0034040643     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(00)00080-2     Document Type: Article

References (33)

1. Andrei G., Snoeck R., De Clercq E. Detection of soluble nuclear matrix protein (NMP) released from apoptotic nuclei of human papillomavirus (HPV) positive cell lines treated with cidofovir. Antiviral Res. 37:1998;A47. (Abstract 26).
2. Christensen N.D., Kreider J.W. Animal models of papillomavirus infections. Zak O., Sande M.A. Handook of Animal Models of Infection. 1999;1039-1047 Academic Press, New York. Chapter 125.
3. Cirelli R., Tyring S.K. Interferons in human papillomavirus infections. Antiviral Res. 24:1994;191-204.
4. Cundy K.C., Lynch G., Lee W.A. Bioavailability and metabolism of cidofovir following topical administration to rabbits. Antiviral Res. 35:1997;113-122.
5. De Clercq E. Acyclic nucleoside phosphonates in the chemotherapy of DNA virus and retrovirus infections. Intervirology. 40:1997;295-303.
6. Gangemi J.D., Pirisi L., Angell M., Kreider J.W. HPV replication in experimental models: effects of interferon. Antiviral Res. 24:1994;175-190.
7. Giri I., Danos O., Yaniv M. Genomic structure of the cottontail rabbit (Shope) papillomavirus. Proc. Natl. Acad. Sci. USA. 82:1985;1580-1584.
8. Gross G. Therapy of human papillomavirus infection and associated epithelial tumors. Intervirology. 40:1997;368-377.
9. Hitchoock M.J.M., Jaffe H.S., Martin J.C., Stagg R.J. Cidofovir, a new agent with potent anti-herpesvirus activity. Antiviral Chem. Chemother. 7:1996;115-127.
10. Howley P.M. Papillomavirinae and their replication. Fields B.N. et al. Virology. 1990;1625-1648 Raven, New York.
11. Kreider J.W., Bartlett G.L. The shope papilloma-carcinoma complex of rabbits: a model system of neoplastic progression and spontaneous regression. Adv. Cancer Res. 35:1981;81-110.
12. Kreider J.W., Baloogh K., Olson R.O., Martin J.C. Treatment of latent rabbit and human papillomavirus infections with 9-(2-phosphonylmethoxy)ethylguanine (PMEG). Antiviral Res. 14:1990;51-58.
13. Kreider J.W., Christensen N.D., Christian C.B., Pickel M.D. Preclinical system for evaluating topical podofilox treatment of papillomas: dose-response and duration of growth prior to treatment. J. Invest. Dermatol. 99:1992;813-818.
14. Kurtzman G., Pickel M., Christensen N., Kreider J. Phosphonate nucleoside analogues are potent anti-papillomavirus agents in animal models. 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. 1993;. (Abstract No. 1593).
15. Laimins L.A. The biology of human papillomaviruses: from warts to cancer. Infect. Agents Dis. 2:1993;74-86.
16. Lalezari J.P. Cidofovir: a new therapy for cytomegalovirus retinitis. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 14(suppl. 1):1997;S22-S26.
17. Majewski S., Jablonska S. Human papillomaviruses - associated tumors of the skin and mucosa. J. Am. Acad. Dermatol. 36:1997;659-685.
18. Naesens L., Snoeck R., Andrei G., Balzarini L., Neyts J., De Clercq E. HPMPC (cidofovir), PMEA (adefovir) and related acyclic nucleoside phosphonate analogues: a review of their pharmacology and clinical potential in the treatment of viral infections. Antiviral Chem. Chemother. 8:1996;1-23.
19. Ostrow R.S., Forslund K.M., McGlennen R.C., Shaw D.R., Schlievert P.M., Ussery M.A., Huggins J.W., Faras A.J. Ribavirin mitigates wart growth in rabbits at early stages of infection with cottontail rabbit papillomavirus. Antiviral Res. 17:1992;99-113.
20. Ostrow R.S., Coughlin S., McGlennen R.C., Lu Z., Zelterman D., Faras A.J. Topical CTC-96 accelerates wart growth in rabbits infected with cottontail rabbit papillomavirus. Antiviral Res. 24:1994;27-35.
21. Pfister H. Biology and biochemistry of papillomaviruses. Rev. Physiol. Biochem. Pharmacol. 99:1984;112-181.
22. Phelps W.C., Alexander K.A. Antiviral therapy for human papillomaviruses: rational and prospects. Ann. Intern. Med. 123:1995;368-382.
23. Phelps W.C., Barnes J.A., Lobe D.C. Molecular targets for human papillomaviruses: prospects for antiviral therapy. Antiviral Chem. Chemother. 9:1998;359-377.
24. Shikowitz M.K. Comparison of pulsed and continuous wave light in photodynamic therapy of papilloma: an experimental study. Laryngoscope. 102:1992;300-310.
25. Shikowitz M.K., Steinberg B.M., Abramson A.L. Hematoporphyrin derivative therapy of papillomas. Arch. Otolaryngol. Head Neck Surg. 112:1986;42-46.
26. Snoeck R., Van Ranst M., Andrei G., De Clercq E., De Wit S., Poncin M., Clumeck N. Treatment of anogenital papillomavirus infection with an acyclic nucleoside phosphate analogue. New Engl. J. Med. 333:1995;943-944.
27. Snoeck R., Bossens M., Parent D., Delaere B., De Greef H., De Clercq E., Safrin S., McGuire B., Jaffe H.S. A double-blind, placebo-controlled study of cidofovir gel for human papillomavirus (HPV) -associated genital warts. Antiviral Res. 37:1998;A47. (Abstract 27).
28. Snoeck R., Wellens W., Desloovere C., Van Ranst M., Naesens L., De Clercq E., Feenstra L. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine]. J. Med. Virol. 54:1998;219-225.
29. Stanley M.A., Masterson P.J., Nicholls P.K. In vitro and animal models for antiviral therapy in papillomavirus infections. Antiviral Chem. Chemother. 8:1997;381-400.
30. Van Cutsem E., Snoeck R., Van Ranst M., Fiten P., Opdenakker G., Geboes K., Janssens L., Rutgeerts P., Vantrappen G., De Clercq E. Successful treatment of a squamous papilloma of the hypopharynx-esophagus by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine. J. Med. Virol. 45:1995;230-235.
31. Zabawski E.J. Jr, Cockerell C.J. Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects. J. Am. Acad. Dermatol. 39:1998;741-745.
32. Zar J.H. Multisample hypotheses: the analysis of variance. Zar J.H. Biostatistical Analysis. second ed:1984;162-184 Prentice-Hall, Englewood Cliffs, NJ.
33. Zar J.H. Multiple comparisons. Zar J.H. Biostatistical Analysis. second ed:1984;185-205 Prentice-Hall, Englewood Cliffs, NJ.